Skip to content
OpenCapital
Get started

AptarGroup ATR EBITDA margin

EBITDA margin at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
25.8%+1.2pp
Amcor logo
AmcorAMCR
12.5%-1.3pp
Nordson logo
NordsonNDSN
30.8%+2.0pp
Baxter International logo
Baxter InternationalBAX
5.9%-6.2pp
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
60.2%+8.7pp
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
3.9%+0.4pp

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S2×-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Calculated from AptarGroup’s reported figures.

ebitda/total revenue=19.3%

Based on trailing twelve months.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's EBITDA margin?
AptarGroup (ATR) reported EBITDA margin of 19.3% in Q1 2026.
How has AptarGroup's EBITDA margin changed year-over-year?
AptarGroup's EBITDA margin decreased by 10.2% year-over-year, from 21.5% to 19.3%.
What is the long-term trend for AptarGroup's EBITDA margin?
Over 5 years (2020 to 2025), AptarGroup's EBITDA margin has grown at a 0.9% compound annual growth rate (CAGR), from 19.1% to 20%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.